The Present and Future
JACC State-of-the-Art Review
Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review

https://doi.org/10.1016/j.jacc.2022.08.714Get rights and content
Under an Elsevier user license
open archive

Highlights

  • Secondary forms of hypertension, when untreated, cause more cardiac damage than primary hypertension and are associated with greater CV risk.

  • Cardiac damage includes not only myocardial hypertrophy but also inflammation, fibrosis, apoptosis, and necrosis.

  • Specific and timely treatment of secondary hypertension is needed to prevent cardiac damage.

Abstract

Several forms of secondary hypertension carry a high risk of cardiac morbidity and mortality. Evaluation of cardiac phenotypes in secondary hypertension provides a unique opportunity to study underlying hormonal and biochemical mechanisms affecting the heart. We review the characteristics of cardiac dysfunction in different forms of secondary hypertension and clarify the mechanisms behind the higher prevalence of heart damage in these patients than in those with primary hypertension. Attention to the specific clinical/biochemical phenotypes of these conditions may assist clinicians to screen for and confirm secondary forms of hypertension. Thereby, early signs of heart damage can be recognized and monitored, allowing individualized treatment to delay or prevent evolution toward more advanced disease.

Key Words

cardiac damage
cardiac events
imaging
secondary hypertension

Abbreviations and Acronyms

BP
blood pressure
CKD
chronic kidney disease
CMR
cardiac magnetic resonance
CoA
coarctation of the aorta
CS
Cushing syndrome
CV
cardiovascular
FMD
fibromuscular dysplasia
GLS
global longitudinal strain
HF
heart failure
LV
left ventricular
LVEF
left ventricular ejection fraction
LVH
left ventricular hypertrophy
LVM
left ventricular mass
LVMI
left ventricular mass index
MACS
mild autonomous cortisol secretion
OSA
obstructive sleep apnea
r-CoA
repaired coarctation of the aorta
RAS
renal artery stenosis
TTS
takotsubo syndrome

Cited by (0)

Listen to this manuscript's audio summary by Editor-in-Chief Dr Valentin Fuster on www.jacc.org/journal/jacc.

The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.

Drs Januszewicz and Mulatero are co-first authors and contributed equally to this work.

Drs Prejbisz and Messerli are co-senior authors and contributed equally to this work.